# Maruho Co., Ltd. clinical trials: 27 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 27 trials with Maruho Co., Ltd. as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Maruho Co., Ltd.: 27 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/maruho-co-ltd

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 27
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 27, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| January 31, 2022 | NCT05214794 | An Open-label, Phase 2 Study to Assess the Efficacy and Safety of Nemolizumab in Subjects With Systemic Sclerosis | Maruho Co., Ltd. | Phase 2 | Completed | Systemic Sclerosis | 6 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05214794) |
| September 28, 2018 | NCT03688971 | Omiganan Twice a Day (BID) in Patients With Facial Seborrheic Dermatitis | Maruho Co., Ltd. | Phase 2 | Unknown | Seborrheic Dermatitis | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03688971) |
| September 26, 2018 | NCT03684772 | Topical Ionic Contra-Viral Therapy in Actinic Keratosis | Maruho Co., Ltd. | Phase 2 | Unknown | Actinic Keratosis | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03684772) |
| November 7, 2017 | NCT03334240 | ICVT in HPV-induced Genital Lesions of Immunocompromised and Immunocompetent Patients | Maruho Co., Ltd. | Phase 2 | Terminated | HPV-Induced Genital Lesions | 28 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03334240) |
| August 23, 2017 | NCT03259620 | A Study to Evaluate the Safety and Efficacy of CLS006 Versus Vehicle in Subjects 2 Years of Age or Older With Cutaneous Common Warts | Maruho Co., Ltd. | Phase 3 | Completed | Cutaneous Common Warts | 491 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03259620) |
| March 27, 2017 | NCT03091426 | Pharmacodynamics of Omiganan BID in Patients With Atopic Dermatitis | Maruho Co., Ltd. | Phase 2 | Completed | Atopic Dermatitis | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03091426) |
| March 7, 2017 | NCT03071679 | Topical Challenge With Omiganan and Imiquimod in Healthy Volunteers | Maruho Co., Ltd. | Phase 1 | Completed | Healthy | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03071679) |
| November 23, 2016 | NCT02971891 | A Phase 3 Study to Evaluate the Efficacy and Safety of CLS006 Versus Vehicle in Subjects 2 Years of Age or Older With Cutaneous Common Warts | Maruho Co., Ltd. | Phase 3 | Completed | Cutaneous Common Warts | 484 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02971891) |
| November 22, 2016 | NCT02970331 | A Phase 2, Multicenter, Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Pefcalcitol Ointment... | Maruho Co., Ltd. | Phase 2 | Withdrawn | Psoriasis | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02970331) |
| July 29, 2016 | NCT02849262 | Pharmacodynamics, Safety and Efficacy of Topical Omiganan in Patients With External Genital Warts | Maruho Co., Ltd. | Phase 2 | Completed | Condylomata Acuminata (External) | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02849262) |
| November 4, 2015 | NCT02596074 | Pharmacodynamics, Safety/Tolerability and Efficacy of Topical Omiganan in Patients With uVIN | Maruho Co., Ltd. | Phase 2 | Completed | Usual Type Vulval Intraepithelial Neoplasia (uVIN) | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02596074) |
| October 15, 2015 | NCT02576860 | Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle | Maruho Co., Ltd. | Phase 3 | Completed | Rosacea | 263 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02576860) |
| October 15, 2015 | NCT02576847 | Study to Evaluate the Long-term Safety of a Once-Daily Omiganan Topical Gel | Maruho Co., Ltd. | Phase 3 | Completed | Rosacea | 307 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02576847) |
| October 8, 2015 | NCT02571998 | A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne... | Maruho Co., Ltd. | Phase 2 | Completed | Acne Vulgaris | 320 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02571998) |
| September 11, 2015 | NCT02547441 | Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle | Maruho Co., Ltd. | Phase 3 | Completed | Rosacea | 463 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02547441) |
| May 28, 2015 | NCT02456480 | Pharmacodynamics of Omiganan (CLS001) in Patients With Atopic Dermatitis | Maruho Co., Ltd. | Phase 2 | Completed | Atopic Dermatitis | 37 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02456480) |
| January 7, 2015 | NCT02333643 | A Phase 2 Efficacy Study of CLS003 ICVT in Subjects With Cutaneous Warts. | Maruho Co., Ltd. | Phase 2 | Completed | Cutaneous Warts | 81 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02333643) |
| August 5, 2014 | NCT02209324 | Open-label Study of ASP2151 in Herpes Simplex Patients | Maruho Co., Ltd. | Phase 3 | Completed | Herpes Simplex | 275 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02209324) |
| April 8, 2014 | NCT02106260 | First-in-Human Study of CLS003 ICVT in Subjects With Cutaneous Warts | Maruho Co., Ltd. | Phase 1/2 | Completed | Cutaneous Warts | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02106260) |
| February 19, 2014 | NCT02066545 | Safety and Efficacy Study of CLS001Topical Gel Compared to Vehicle in Subjects With Inflammatory Acne Vulgaris | Maruho Co., Ltd. | Phase 2 | Completed | Acne Vulgaris | 327 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02066545) |
| January 7, 2014 | NCT02028286 | A 21 Day Pharmacokinetics Study in Papulopustular Rosacea | Maruho Co., Ltd. | Phase 1 | Completed | Papulopustular Rosacea | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02028286) |
| October 10, 2013 | NCT01959841 | Phase III Study of ASP2151 in Herpes Zoster Patients | Maruho Co., Ltd. | Phase 3 | Completed | Herpes Zoster | 751 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01959841) |
| October 10, 2013 | NCT01959295 | Phase III Study of ASP2151 in Herpes Simplex Patients | Maruho Co., Ltd. | Phase 3 | Completed | Herpes Simplex | 468 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01959295) |
| February 5, 2013 | NCT01784133 | A Twelve Week Safety and Efficacy Study in Rosacea | Maruho Co., Ltd. | Phase 2 | Completed | Papulopustular Rosacea | 240 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01784133) |
| February 23, 2011 | NCT01301157 | Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients | Maruho Co., Ltd. | Phase 2 | Completed | Plaque Psoriasis | 294 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01301157) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 2 |
| Phase 1/2 | 1 |
| Phase 2 | 16 |
| Phase 3 | 8 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 23 |
| Unknown | 2 |
| Terminated | 1 |
| Withdrawn | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Rosacea | 5 |
| Dermatitis, Atopic | 3 |
| Acne Vulgaris | 2 |
| Herpes Simplex | 2 |
| Condylomata Acuminata | 1 |
| Scleroderma, Systemic | 1 |
| Keratosis, Actinic | 1 |
| Psoriasis | 1 |
| Herpes Zoster | 1 |
| Dermatitis, Seborrheic | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Live and raw food restaurants in the United States](https://specstream.ai/data/businesses/live-and-raw-food-restaurants/united-states)
- [Public relations firms in the United States](https://specstream.ai/data/businesses/public-relations-firms/united-states)
- [Walk-in clinics in the United States](https://specstream.ai/data/businesses/walk-in-clinics/united-states)
- [Building contractors in the United States](https://specstream.ai/data/businesses/building-contractors/united-states)
- [Event technology companies in the United States](https://specstream.ai/data/businesses/event-technology-companies/united-states)
- [Landscaping companies in the United States](https://specstream.ai/data/businesses/landscaping-companies/united-states)
